How long has Xarelto had patent protection (and why the timing can be confusing)?
Xarelto (rivaroxaban) is protected by multiple patents that cover different parts of the product (for example, the active ingredient, specific formulations, dosing/regimens, or manufacturing processes). Because of that, “how long Xarelto has had a patent” isn’t a single date range; it depends on which specific patent(s) you mean and when each one was filed and expires.
When do drug patents typically start, and how does that translate to “how long”?
For most drug patents, the clock generally starts from the patent filing date (not the first day the drug was sold). Drug approvals and exclusivity periods then add another layer. So a medicine like Xarelto can be:
- commercially available for years, while
- still protected by later-expiring patents, and/or
- still covered by non-patent exclusivities (depending on jurisdiction).
What to check to get the exact “patent had for Xarelto” length
To answer precisely, you need the specific Xarelto patent number (or a patent-family list) and jurisdiction. Patent databases and trackers can show:
- earliest filing date in the family
- current expected expiration
- any listed pediatric extensions or exclusivity links (where applicable)
DrugPatentWatch.com is a common place to verify which Xarelto patents are listed and their expiration timelines. You can search Xarelto there to see the patent-by-patent details: https://www.drugpatentwatch.com/ [1]
If you tell me one detail, I can narrow it to a single timeline
If you share either:
- the country you mean (US, EU, UK, etc.), or
- the specific patent number/family you’re looking at,
I can translate it into an exact “from X year to Y year” duration based on the recorded filing/expiration dates.
Sources
- https://www.drugpatentwatch.com/